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Abstract
Introduction
Neonatal jaundice is one of the most common reasons for hospital admission in low
resource settings. Treatment is frequently inadequate as conventional phototherapy
requires frequent bulb changes. LED phototherapy has comparable efficacy to conventional
phototherapy, and the bulbs last over 40,000 hours. This observational study compares the
effectiveness of three LED machines, two single-sided and one double-sided in routine use
in Vietnam.
Methods
We included all infants weighting1500g and with jaundice diagnosed visually or by Total
Serum Bilirubin (TSB) measurement at The Da Nang Hospital for Women and Children (Da
Nang, Vietnam). The primary endpoint was the average hourly change in TSB over the first
six hours of treatment. The secondary endpoints were duration of treatment; average hourly
change in TSB over treatment, and length of stay in the neonatal unit. Multivariable analysis
and bootstrap methods was performed to compare outcomes, adjusting for potential
confounders.
Results
All outcomes were comparable in the two single-sided machines. The double-sided machine
showed 54% increase in the hourly speed of TSB reduction (1.3 μmol/L/hr, 95% CI 0.3–2.3),
with a 45% increase in the speed of TSB reduction over the duration of treatment (0.9 μmol/
L/hr, 95% CI 0.6–1.3). In addition, the double-sided machine was associated with 21%
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reduction in the duration of treatment (14 hours, 95% CI 5–22) and 16% reduction of length
of stay (14 hours, 95% CI 3–25).
Conclusion
The results confirm and quantify the benefits of increasing surface-area exposure during
phototherapy. Adjusted for multiple potential confounders, use of double-sided photother-
apy can substantially increase the speed of TSB reduction, and substantially decrease the
duration of treatment and length of stay in the NCU.
Introduction
Neonatal jaundice is a common condition affecting over 60% of neonates, and frequently
requiring medical attention [1]. While usually benign, sustained elevated bilirubin levels can
occasionally result in permanent neurological damage or death, but these outcomes can be
prevented through appropriate management. This has been largely, but not entirely, achieved
in high-resource settings [2, 3].
In low resource settings (LRSs), treatment of neonatal jaundice is often sub-optimal [4, 5].
Conventional fluorescent light phototherapy is often the only available option in LRSs, and the
irradiance provided is usually below recommended levels [6–8]. Common reasons for low irra-
diance include: using white fluorescent bulbs with low irradiance in the efficacious spectrum
for treatment of jaundice; and failure to replace blue bulbs on a regular basis (typically 1,000–
2,000 hours) due to cost, lack of a photo radiometer to monitor irradiance, or lack of an on-
machine counter to track hours of use. Sub-optimal phototherapy treatment can lead to long
lengths of stay while jaundice resolves spontaneously, and the lack of effective phototherapy
can lead to a need for exchange transfusion [8]; both outcomes pose additional risks to neo-
nates, and have resource implications for facilities caring for sick neonates in LRSs.
A Cochrane Review found that LED and non-LED (halogen or fluorescent bulb) photother-
apy result in a comparable rate of reduction of total serum bilirubin (TSB) [9]. The cost of
LED phototherapy has reduced markedly in recent years, and LED phototherapy bulbs typi-
cally have a 40,000–50,000 hour lifespan, eliminating the need for frequent replacement of
bulbs, making it an affordable technology for LRSs and creating the opportunity for high qual-
ity phototherapy to be consistently provided in LRS.
The aim of the present study was to compare three different LED machines, two single-
sided and one double-sided, in speed of reduction of TSB, duration of treatment with photo-
therapy, and total length of stay (LOS). The study was undertaken as part of a program of oper-
ational research to inform programming decisions by an international non-government
organization (INGO) that donates LED phototherapy to hospitals in LRSs.
Materials and methods
Setting
The Da Nang Hospital for Women and Children, located in south-central Viet Nam, had
13,411 births in 2014 and its Neonatal Care Unit (NCU) accepted 3,934 admissions, born at
the hospital or transferred in, of which 1,207 (30.7%) were for jaundice. The hospital had sev-
eral LED and conventional phototherapy machines prior to study commencement. Neonates
were enrolled in the study from May 2013 to September 2014.
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Study population
The study population was restricted to infants born weighing1500g, with jaundice diag-
nosed visually or by TSB, and having their first episode of phototherapy at the hospital. Infants
with gestational age<33 weeks, those with axillary temperature <36.5˚C or >37.5˚C at treat-
ment commencement and those treated in an incubator were excluded.
Intervention
The study compared three LED phototherapy machines specifically designed for LRSs
(Table 1). Two machines provide single-sided phototherapy from above (“PTV3000” and “Lul-
laby”), while the third (“Firefly”) is double-sided. The lamp heads of both single-sided
machines can be adjusted to provide therapy at various distances from the baby, altering the
irradiance, while the double-sided device provides treatment at a fixed distance from both
above and below. The Firefly has a single irradiance setting while both single-sided machines
have two settings and can be put into high-irradiance mode by flicking a switch; the PTV3000
automatically reverts to standard mode after 3 hours, while the Lullaby must be manually
switched back. No restrictions were placed on the hospital’s use of the single-sided machines,
in relation to the distance of the lights from the neonate, or the irradiance setting to be used.
Allocation
While the study was observational, an un-blinded system of quasi-randomisation was devised.
As the NCU had limited space, only one machine of each type was provided for the study, and
it would have prolonged the study if infants could only be allocated when all three machines
were available. Eligible infants were allocated in a standard order, based on a number assigned
to each device: the PTV3000 was assigned #1, the Lullaby #2 and the Firefly #3. Allocation was
to the available machine where only one was available, or to the lower numbered machine if
two or more were available.
Table 1. Key features of the three LED phototherapy machines.
PTV3000 Lullaby Firefly
Manufacturer MTTS, Hanoi, Vietnam GE Healthcare, Maryland, USA MTTS, Hanoi, Vietnam
Type Single-sided Single-sided Double-sided
Weight 18.4 kg 10 kg 13 kg
Irradiance settings Two: Standard/High
[High setting reverts to low automatically
after 3 hours use]
Two: Standard/High
[High setting is changed by manually flicking a
switch]
Single setting
Fixed/adjustable treatment
distance
Adjustable Adjustable (and head is detachable allowing place
atop an incubator)
Fixed
Irradiance from above Standard: 25 μW/nm/cm2
High: 40 μW/nm/cm2
[Measured at 40 cm]
Standard: 22 μW/nm/cm2
High: 45 μW/nm/cm2
[Measured at 35 cm]
32 μW/nm/cm2
[Fixed distance]
Irradiance from below N/A N/A 36 μW/nm/cm2
[Fixed distance]
LED bulb type
[dominant wavelength]
Luxeon Rebel Royal Blue, High Power
[450–475 nm]
Cree
[450–465 nm]
Seoul Semiconductor Blue High
Power
[453–465 nm]
Number of bulbs 42 10 10 above + 18 below
Expected bulb life# 50,000 50,000 44,000
 As per manufacturer’s specification.
# Estimated hours of use before reaching 70% lumen maintenance (i.e., 30% reduction in irradiance)
https://doi.org/10.1371/journal.pone.0205432.t001
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Data
To minimise the data collection burden, no data was collected on eligible babies that were
excluded for any reason. For enrolled infants, data was collected on several factors including:
estimated gestational age; birthweight, date and time of birth; inborn/outborn status; sex;
maternal and infant blood type and direct Coomb’s test; Rh(D) status; G6PD deficiency; previ-
ous sibling received phototherapy; significant bruising; exclusive breastfeeding and feeding
poorly; date and time and TSB (μmol/L) at treatment start and at end, and TSB at 6 hours; date
and time of nursery admission and discharge; selected treatments that could influence length
of stay (oxygen; antibiotics); machine allocation; and machine used for treatment. Data was
collected by hospital clinicians on individual paper forms, and forwarded to project staff for
entry in a database.
Endpoints
The primary endpoint was change in TSB/hour, over the first six hours of treatment, to pro-
vide information about the relative efficacy of the machines with minimal opportunity for con-
founding. The secondary endpoints were: duration of phototherapy; change in TSB/hour over
the whole duration of treatment; and LOS in the NCU. For each endpoint, a comparison of the
three phototherapy machines and by a comparison of single vs. double sided machines were
performed.
Power
The power of the study was based on a planned recruitment of 300 infants. Because of the
unbalanced allocation built into the design, it was noted that the Firefly would have the lowest
number of infants. Means and standard deviations were unknown; allocation of 63 infants per
group allowed detection of a difference of half a standard deviation in pairwise means; by
enrolling 300 infants, we anticipated 63 infants in all three groups, and capacity to detect
this difference or more.
Statistical analysis
Categorical data were expressed as number and percentage, while continuous data as median
and interquartile range (IQR). Demographics and risk factors for hyperbilirubinemia were
compared among the three phototherapy groups using Fisher’s Exact test or Kruskal-Wallis
test, as appropriate. Multivariable analysis of primary and secondary endpoints was performed
using ordinary least squares (OLS) regression, adjusting for potential confounders that were
reported in 10 or more infants. As the distributions were only approximately normal, statistical
significance was confirmed using bootstrap methods to calculate 95% Confidence Intervals
(CIs), which were compared to CIs produced by OLS. Sampling for bootstrap analysis was
with replacement, undertaken within each allocation group to create 10,000 samples of the
same size and treatment group composition as the original; the final OLS model was re-run on
each of the samples and parameter estimates saved; for each of the parameters estimated, the
mean of each parameter was calculated, and the 2.5th and 97.5th percentile were used as the
bounds of the bootstrap 95% CIs [10]. The average change in endpoint was calculated using
OLS parameter estimates and the mean value or prevalence for each potential confounder. The
duration outcomes (duration of treatment and LOS in the NCU) were positively skewed, thus
were log-transformed before analysis. Since the transformed outcomes did not meaningfully
improve model fit or alter the statistical significance, results of untransformed models were
reported to ease interpretation of results. Analysis was based on the principle of ‘intention to
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treat’ and included a comparison of the three phototherapy machines, followed by a compari-
son of single vs. double sided machines. All tests were two-tailed and analysis was performed
using SAS 9.4 (SAS Institute, Cary, NC).
Ethical approval
The Ethics Committee at the Da Nang Hospital for Women and Children approved the study
and waived the need for consent given the observational design of the study.
Results
Patients
At study completion, 310 infants had been allocated to the three machines: 113 to the
PTV3000, 104 to the Lullaby, and 93 to the Firefly. All infants were treated on the machines to
which they were assigned; 26% commenced treatment <72 hours of age, and 25% commenced
treatment >120 hours of age. Median TSB at the start of treatment was 287 μmol/L (IQR 255–
328). Patient characteristics are shown in Table 2. Infants allocated to Firefly were less likely to
commence treatment <72 hours of age (p<0.05) and had higher median TSB at start of
Table 2. Patient characteristics by treatment allocation.
Total Specific machine Machine type
PTV3000 Lullaby Firefly p-value Single Double p-value
n 310 113 104 93 217 93
Place of birth Inborn 247 (79.7) 92 (81.4) 83 (79.8) 72 (77.4) 0.70 175 (80.7) 72 (77.4) 0.42
Outborn 57 (18.4) 19 (16.8) 18 (17.3) 20 (21.5) 37 (17.1) 20 (21.5)
Missing 6 (1.9) 2 (1.8) 3 (2.9) 1 (1.1) 5 (2.3) 1 (1.1)
Sex Male 183 (59.0) 59 (52.2) 63 (60.6) 61 (65.6) 0.14 122 (56.2) 61 (65.6) 0.17
Female 126 (40.6) 54 (47.8) 40 (38.5) 32 (34.4) 94 (43.3) 32 (34.4)
Missing 1 (0.3) 0 (0.0) 1 (1.0) 0 (0.0) 1 (0.5) 0 (0.0)
Birthweight, Grams 3100 3170 3100 3109 0.44 3100 3109 0.60
(2840–3400) (2900–3400) (2800–3355) (2900–3400) (2800–3400) (2900–3400)
35–38 weeks gestation No 209 (67.4) 82 (72.6) 69 (66.3) 58 (62.4) 0.31 151 (69.6) 58 (62.4) 0.19
Yes 99 (31.9) 31 (27.4) 33 (31.7) 35 (37.6) 64 (29.5) 35 (37.6)
Missing 2 (0.6) 0 (0.0) 2 (1.9) 0 (0.0) 2 (0.9) 0 (0.0)
G6PD Not tested 298 (96.1) 109 (96.5) 101 (97.1) 88 (94.6) 0.55 210 (96.8) 88 (94.6) 0.52
Sufficiency 9 (2.9) 4 (3.5) 2 (1.9) 3 (3.2) 6 (2.7) 3 (3.2)
Deficiency 3 (1.0) 0 (0.0) 1 (1.0) 2 (2.2) 1 (0.5) 2 (2.2)
ABO (Coombs +ve) Not tested 9 (2.9) 3 (2.6) 6 (5.8) 0 (0.0) 0.75 9 (4.2) 0 (0.0) 0.51
Negative 299 (96.5) 109 (96.5) 98 (94.2) 92 (98.9) 209 (96.3) 92 (98.9)
Positive 2 (0.6) 1 (0.9) 0 (0.0) 1 (1.1) 1 (0.5) 1 (1.1)
Infection (treated with antibiotics) No 272 (87.7) 95 (84.1) 93 (89.4) 84 (90.3) 0.33 188 (86.6) 84 (90.3) 0.45
Yes 38 (12.3) 18 (15.9) 11 (10.6) 9 (9.7) 11 (13.4) 9 (9.7)
TSB at start of treatment μmol/L 287 277 276 308 <0.001 277 308 <0.001
(255–328) (255–327) (250–301) (275–346) (253–317) (275–346)
Age at start of treatment <72 hours 80 (25.8) 35 (31.0) 30 (28.9) 15 (16.1) 0.04 65 (29.9) 15 (16.1) 0.01
72–120 hours 137 (44.2) 44 (38.9) 41 (39.4) 52 (55.9) 85 (39.2) 52 (55.9)
>120 hours 77 (24.8) 28 (24.8) 28 (26.9) 21 (22.6) 56 (25.8) 21 (22.6)
Missing 16 (5.2) 6 (5.3) 5 (4.8) 5 (5.4) 11 (5.1) 5 (5.4)
Data expressed as n (%) or median (IQR). Comparisons were performed excluding missing data.
https://doi.org/10.1371/journal.pone.0205432.t002
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treatment (p<0.001). No infant was: Rh(D) positive; born to a multiparous Rh(D) negative
mother; having received oxygen; having a previous sibling who received phototherapy; having
significant bruising; or breastfeeding exclusively and feeding poorly.
Primary outcome
Over first six hours, Firefly lowered the TSB faster than PTV3000 (mean difference 1.51 μmol/
L, 95% CI -2.56 to -0.45), while TSB decrease was similar with Lullaby and PTV3000 (mean
difference 0.48 μmol/L, 95% CI -1.54 to 0.58) (Table 3). These findings were confirmed in dou-
ble- vs. single-sided comparison (mean difference -1.29 μmol/L, 95% CI -2.34 to -0.26)
(Table 3). OLS and bootstrap analyses showed comparable estimates.
Secondary outcomes
As with the primary endpoint, the two single-sided machines (Lullaby than PTV3000) showed
comparable results regarding the secondary endpoints (Tables 4–6). Double-sided photother-
apy was associated with a 13.8-hour reduction in the duration of treatment (95% CI 5.7 to
22.8; Table 4). The average duration of treatment was 64.7 hours on single-sided phototherapy
and 50.9 hours on double-sided, which represents a 21% reduction in treatment duration.
Table 3. Change in TSB per hour (μmol/L) over first six hours.
Univariate analysis Multivariable analysis
3 machine comparison Single vs double
OLS OLS Bootstrap OLS Bootstrap
Pt. Est. Pt. Est. Pt. Est. Pt. Est. Pt. Est.
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Intercept Intercept Various -2.04 (-6.47 to 2.38) -2.04 (-6.05 to 2.22) -2.41 (-6.77 to 1.95) -2.39 (-6.57 to 1.88)
Machine # PTV3000 Ref Ref Ref - -
Lullaby -0.18 (-1.34 to 0.97) -0.50 (-1.55 to 0.55) -0.48 (-1.54 to 0.58)
Firefly -1.81 (-2.98 to -0.64) -1.50 (-2.60 to -0.40) -1.51 (-2.56 to -0.45)
Machine type Single-sided Ref - - Ref Ref
Double-sided -1.72 (-2.76 to -0.69) -1.27 (-2.26 to -0.28) -1.29 (-2.34 to -0.26)
Place born Inborn Ref Ref Ref Ref Ref
Outborn -0.80 (-2.08 to 0.48) -0.20 (-1.40 to 0.99) -0.20 (-1.56 to 1.13) -0.22 (-1.41 to 0.97) -0.20 (-1.65 to 1.15)
Birthweight kg 2.01 (0.79 to 3.23) 2.42 (1.27 to 3.57) 2.42 (1.09 to 3.75) 2.43 (1.28 to 3.58) 2.43 (1.03 to 3.77)
Sex Female Ref Ref Ref Ref Ref
Male 0.39 (-0.59 to 1.38) 0.15 (-0.76 to 1.05) 0.15 (-0.77 to 1.07) 0.13 (-0.78 to 1.03) 0.13 (-0.80 to 1.06)
35–38 weeks No Ref Ref Ref Ref Ref
Yes 0.74 (-0.29 to 1.77) 0.92 (-0.04 to 1.89) 0.92 (0.002 to 1.81) 0.92 (-0.05 to 1.88) 0.91 (-0.01 to 1.93)
Infection treated with antibiotics No Ref Ref Ref Ref Ref
Yes -1.55 (-3.00 to -0.11) -2.04 (-3.42 to -0.66) -2.03 (-3.58 to -0.55) -1.99 (-3.36 to -0.62) -1.98 (-3.48 to -0.54)
Age at start of phototherapy^ <72 hours -0.30 (-1.46 to 0.85) -0.26 (-0.88 to 1.39) -0.25 (-0.80 to 1.32) -0.26 (-0.88 to 1.39) -0.25 (-0.83 to 1.32)
72–120 hours Ref Ref Ref Ref Ref
>120 hours -1.81 (-2.99 to -0.64) -1.00 (-2.15 to 0.15) -1.00 (-2.15 to -0.14) -1.01 (-2.16 to 0.13) -1.02 (-2.15 to 0.11)
TSB at start of phototherapy /100 μmol/L -2.81 (-3.66 to -1.96) -2.56 (-3.43 to -1.69) -2.56 (-3.78 to -1.35) -2.52 (-3.39 to -1.66) -2.52 (-3.70 to -1.35)
OLS: Ordinary Least Squares Regression. Pt. Est.: Point Estimate. 95% CI: 95% Confidence Interval.
# Overall p-values for overall machine effect: univariate: p = 005; multivariable: p = 0.03.
^ Overall p-values for overall effect of age at start of treatment: univariate: p = 009; multivariable three-machine: p = 0.13; multivariable: p = 0.12.
https://doi.org/10.1371/journal.pone.0205432.t003
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More than half of all phototherapy treatments ceased on the hour, between 7–11 am, likely
reflecting clinical schedules for patient review.
Double-sided phototherapy resulted in TSB reduction at a rate 0.94 μmol/L/hr faster (95%
CI 0.62 to 1.29) than single-sided over the whole duration of treatment (Table 5). The average
rate of TSB reduction was 2.1 μmol/L/hr on the single-sided phototherapy and 3.0 μmol/L/hr
on the double-sided, representing a 45% increase in the rate of TSB reduction over the whole
duration of treatment.
Double-sided phototherapy resulted in a 14-hour shorter LOS in the NCU (95% CI 3 to 25;
Table 6). The average LOS in the NCU for this study population was 87 hours on single-sided
phototherapy and 73 hours on double-sided, representing a 16% reduction in LOS. OLS and
bootstrap analyses showed comparable estimates. The time of discharge from the NCU showed
a likely practice schedule: 88% of discharges from the unit were at 7, 8 or 11am, or at 2 or 5
pm.
Discussion
Neonatal jaundice is one of the most common conditions requiring hospital admission [1],
and has been reported to be responsible for half of admissions to NCUs in some LRSs [8]. Pre-
vention, accurate diagnosis and effective treatment are all important elements of jaundice
management [11]. This study focused on effective treatment and compared different LED
Table 4. Duration of phototherapy (hours).
Univariate analysis Multivariable analysis
3 machine comparison Single vs double
OLS OLS Bootstrap OLS Bootstrap
Pt. Est. Pt. Est. Pt. Est. Pt. Est. Pt. Est.
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Intercept Intercept Various 3.0 (-35.2 to 41.2) 2.9 (-33.2 to 37.6) 2.2 (-35.4 to 39.7) 2.3 (-33.0 to 36.7)
Machine # PTV3000 Ref Ref Ref - -
Lullaby -4.5 (-14.1 to 5.1) -1.1 (-10.1 to 7.9) -1.0 (-10.7 to 8.2)
Firefly -11.2 (-21.0 to -1.4) -14.3 (-23.7 to -4.8) -14.1 (-25.8 to -3.9)
Machine type Single-sided Ref - - Ref Ref
Double-sided -9.1 (-17.8 to -0.4) -13.8 (-22.3 to -5.3) -13.8 (-22.8 to -5.7)
Place born Inborn Ref Ref Ref Ref Ref
Outborn -1.3 (-11.9 to 9.3) -5.3 (-15.6 to 5.0) -5.2 (-15.2 to 4.3) -5.3 (-15.6 to 4.9) -5.3 (-15.4 to 4.4)
Birthweight kg 4.0 (-14.3 to 6.2) -1.9 (-11.8 to 8.1) -1.7 (-16.0 to 10.5) -1.8 (-11.8 to 8.1) -1.8 (-16.1 to 10.4)
Sex Female Ref Ref Ref Ref Ref
Male -6.0 (-14.1 to 2.1) -3.2 (-11.0 to 4.6) -3.3 (-10.3 to 4.3) -3.2 (-11.0 to 4.6) -3.3 (-10.4 to 4.2)
35–38 weeks No Ref Ref Ref Ref Ref
Yes 4.9 (-3.7 to 13.4) 9.6 (1.2 to 17.9) 9.3 (0.4 to 19.3) 9.5 (1.2 to 17.8) 9.4 (0.6 to 19.4)
Infection treated with antibiotics No Ref Ref Ref Ref Ref
Yes 20.0 (8.2 to 31.8) 20.4 (8.5 to 32.3) 20.5 (8.5 to 32.2) 20.5 (8.7 to 32.3) 20.5 (8.7 to 32.4)
Age at start of phototherapy^ <72 hours 9.6 (-0.1 to 19.2) 4.2 (-5.6 to 14.0) 4.1 (-4.0 to 12.6) 4.2 (-5.6 to 14.0) 4.1 (-4.0 to 12.8)
72–120 hours Ref Ref Ref Ref Ref
>120 hours 7.6 (-2.2 to 17.4) 3.7 (-6.2 to 13.6) 3.5 (-5.7 to 14.0) 3.7 (-6.2 to 13.5) 3.7 (-5.7 to 14.1)
TSB at start of phototherapy /100 μmol/L 17.1 (9.8 to 24.3) 21.4 (13.9 to 28.9) 21.2 (11.5 to 32.6) 21.5 (14.0 to 28.9) 21.4 (11.4 to 33.7)
OLS: Ordinary Least Squares Regression. Pt. Est.: Point Estimate. 95% CI: 95% Confidence Interval.
# Overall p-values for overall machine effect: univariate: p = 0.08; multivariable: p = 0.007
^ Overall p-values for overall effect of age at start of treatment: univariate: p = 0.10; multivariable three-machine: p = 0.63; multivariable: p = 0.63.
https://doi.org/10.1371/journal.pone.0205432.t004
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phototherapy machines designed for use in LRSs in term of speed of TSB reduction and dura-
tion of treatment. Speed of TSB reduction is important in preventing higher-risk interventions
such as exchange transfusion, while duration of treatment and LOS impact workload in NCUs
and the number of infants that can potentially benefit from treatment.
After adjusting for TSB at the start of treatment, and other potential confounders, the two
single-sided machines (PTV3000 and Lullaby) showed no difference in the speed of TSB
reduction, in duration of treatment and in LOS in the NCU.
Increasing the surface-area exposed to light has been routinely recommended for improv-
ing the effectiveness of phototherapy [12–14]. Several studies compared single- and double-
sided phototherapy to increase surface area, with conflicting results. Some reported faster
speed of reduction and/or shorter duration of treatment with double-sided treatment [15–20],
but others showed no difference in a simple comparison [21]. or where the total irradiance was
identical in the single or double-sided configurations [22], or where single-sided therapy was
augmented with reflecting curtains [23].
Here we assessed, for first the first time, the effectiveness on TSB reduction of a single- vs
double-sided LED phototherapy machines specifically designed for use in LRSs; robust and
simple to use. After controlling for potential confounders, the double-sided machine had a
rate of TSB reduction which was 54% faster in the first 6 hours of treatment, and 45% faster
over the duration of treatment. After adjustment, double-sided treatment was also associated
Table 5. Change in TSB per hour (μmol/L) over treatment.
Univariate analysis Multivariable analysis
3 machine comparison Single vs double
OLS OLS Bootstrap OLS Bootstrap
Pt. Est. Pt. Est. Pt. Est. Pt. Est. Pt. Est.
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Intercept Intercept Various -0.48 (-2.07, 1.10) -0.49 (-2.00, 1.00) -0.65 (-2.22, 0.93) -0.66 (-2.21, 0.83)
Machine # PTV3000 Ref Ref Ref - -
Lullaby -0.29 (-0.70, 0.11) -0.28 (-0.66, 0.10) -0.28 (-0.66, 0.07)
Firefly -1.20 (-1.60, -0.79) -1.08 (-1.48, -0.68) -1.09 (-1.48, -0.73)
Machine type Single-sided Ref - - Ref Ref
Double-sided -1.04 (-1.40, -0.70) -0.94 (-1.29, -0.59) -0.94 (-1.29, -0.62)
Place born Inborn Ref Ref Ref Ref Ref
Outborn -0.05 (-0.43, 0.52) 0.33 (-0.11, 0.76) 0.33 (-0.11, 0.76) 0.31 (-0.13, 0.75) -0.31 (-0.12, 0.73)
Birthweight kg 0.02 (-0.02, 0.4) 0.21 (-0.19, 0.61) 0.21 (-0.15, 0.60) 0.23 (-0.18, 0.63) 0.23 (-0.14, 0.62)
Sex Female Ref Ref Ref Ref Ref
Male -0.11 (-0.47, 0.26) -0.09 (-0.42, 0.24) -0.09 (-0.42, 0.24) -0.11 (-0.44, 0.21) -0.11 (-0.45, 0.23)
35–38 weeks No Ref Ref Ref Ref Ref
Yes 0.27 (-011, 0.66) 0.34 (-0.02, 0.69) 0.34 (0.03, 0.65) 0.32 (-0.03, 0.68) 0.32 (0.02, 0.63)
Infection treated with antibiotics No Ref Ref Ref Ref Ref
Yes 0.51 (-0.04, 1.07) 0.28 (-0.23, 0.80) 0.29 (-0.21, 0.79) 0.29 (-0.22, 0.80) 0.29 (-0.21, 0.79)
Age at start of phototherapy^ <72 hours -0.16 (-0.26, 0.57) -0.15 (-0.55, 0.24) -0.16 (-0.60, 0.24) -0.15 (-0.55, 0.24) -0.15 (-0.61, 0.25)
72–120 hours Ref Ref Ref Ref Ref
>120 hours -0.58 (-1.02, -0.15) -0.59 (-1.00, -0.17) -0.59 (-1.02, -0.18) -0.60 (-1.01, -0.19) -0.60 (-1.04, -0.18)
TSB at start of phototherapy /100 μmol/L -1.00 (-1.32, -0.69) -0.69 (-1.02, -0.37) -0.69 (-1.05, -0.31) 0.69 (-1.02, -0.37) -0.69 (-1.05, -0.29)
OLS: Ordinary Least Squares Regression. Pt. Est.: Point Estimate. 95% CI: 95% Confidence Interval.
# Overall p-values for overall machine effect: univariate: p<0.0001; multivariable: p<0.0001
^ Overall p-values for overall effect of age at start of treatment: univariate: p = 0.006; multivariable three-machine: p = 0.02; multivariable: p = 0.02
https://doi.org/10.1371/journal.pone.0205432.t005
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with an 14-hour reduction in the duration of treatment, and a 14-hour reduction in LOS in
the NCU. It is notable that the PTV3000 has white curtains and a method of fixing them in
place, and clinicians confirm that these curtains were routinely used during treatment. How-
ever, consistent differences were still found between PTV3000 and the double-sided Firefly in
speed of TSB reduction, and in duration of treatment and LOS.
From a planning point of view, a combination of different types of phototherapy devices in
an NCU is likely to be optimal, depending on the funds available and cost of the machines. An
increasing number of different LED phototherapy machines are being developed for use in
LRSs, but the cost and availability of any particular machine can vary enormously from one
LRS to another. Where available and affordable, replacing conventional phototherapy with
LED can solve the problem of ineffective phototherapy being provided in LRSs, reducing
ongoing administrative and financing costs associated with the supply of replaceable bulbs.
For infants that can thermoregulate, and in settings where ambient temperature is adequate,
double-sided Firefly can lead to faster reduction in TSB, a shorter duration of treatment and a
shorter LOS in the NCU.
Given the known and potential side-effects associated with phototherapy [24], clinical
schedules which optimise treatment durations are justified. In the current study, all TSB test-
ing was conducted in the hospital laboratory, with longer delays expected for TSB results
requested at night, or on weekends. The availability of affordable and reliable TSB testing
Table 6. LOS in NCU (hours).
Univariate analysis Multivariable analysis
3 machine comparison Single vs double
OLS OLS Bootstrap OLS Bootstrap
Pt. Est. Pt. Est. Pt. Est. Pt. Est. Pt. Est.
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Intercept Intercept Various 45.0 (-2.4, 92.4) 44.8 (-0.02, 90.3) 44.0 (-2.6, 90.7) 43.8 (0.8, 87.7)
Machine # PTV3000 Ref Ref Ref - -
Lullaby -7.9 (-21.4, 5.5) -1.4 (-12.6, 9.9) -1.5 (-13.6, 10.8)
Firefly -15.2 (-28.9, -1.6) -14.6 (-26.4, -2.8) -14.5 (-27.2, -2.9)
Machine type Single-sided Ref - - Ref Ref
Double-sided -11.5 (-23.7, 0.6) -14.0 (-24.6, -3.4) -13.7 (-24.7, -3.3)
Place born Inborn Ref Ref Ref Ref Ref
Outborn -0.2 (-15.0, 14.7) -6.4 (-19.2, 6.4) -6.5 (-20.7, 9.4) -6.5 (-19.3, 6.3) 6.6 (-20.9, 9.4)
Birthweight kg -14.3 (-28.5, -0.02) -10.8 (-23.1, 1.6) -10.4 (-27.2, 4.5) -10.7 (-23.0, 1.6) -10.4 (-27.0, 4.7)
Sex Female Ref Ref Ref Ref Ref
Male -5.5 (-16.9, 5.9) 1.6 (-8.2, 11.3) 1.2 (-8.6, 12.1) 1.5 (-8.2, 11.2) 1.2 (-9.0, 11.9)
35–38 weeks No Ref Ref Ref Ref Ref
Yes 0.5 (-12.5, 11.5) 3.5 (-6.9, 13.9) 3.4 (-7.4, 14.3) 3.5 (-6.9, 13.9) 3.4 (-7.4, 14.6)
Infection treated with antibiotics No Ref Ref Ref Ref Ref
Yes 74.0 (60.4, 89.1) 76.2 (61.4, 91.0) 76.3 (55.7, 99.4) 76.3 (61.6, 91.0) 76.2 (55.9, 99.1)
Age at start of phototherapy^ <72 hours 21.5 (8.1, 34.9) 2.0 (-10.2, 14.2) 1.9 (-8.9, 13.2) 2.0 (-10.2, 14.2) 1.9 (-8.6, 12.9)
72–120 hours Ref Ref Ref Ref Ref
>120 hours 9.3 (-4.2, 22.8) 5.9 (-6.4, 18.2) 5.8 (-7.0, 18.7) 5.9 (-6.4, 18.2) 5.8 (-7.0, 18.8)
TSB at start of phototherapy /100 μmol/L 15.0 (46.1, 25.3) 21.6 (12.3, 30.9) 21.4 (8.3, 35.8) 21.7 (12.5, 31.0) 21.5 (8.3, 35.9)
OLS: Ordinary Least Squares Regression. Pt. Est.: Point Estimate. 95% CI: 95% Confidence Interval.
# Overall p-values for overall machine effect: univariate: p = 0.09; multivariable: p = 0.03
^ Overall p-values for overall effect of age at start of treatment: univariate: p = 0.007; multivariable three-machine: p = 0.64; multivariable: p = 0.64.
https://doi.org/10.1371/journal.pone.0205432.t006
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within the NCU, to determine whether it is appropriate to cease treatment, could help modify
these schedules [25], In addition, we noted a strong preference for phototherapy to end at
7–11 am, implying that treatment may be continuing longer than required, to fit clinical
schedules. Similarly, we identified a practice pattern for infants to be discharged at particular
times of the day. If confirmed, more frequent clinical review could result in shorter treatment
duration and shorter LOS. Moreover, given the overcrowding found in many NCUs in LRSs,
and the associated exposure to nosocomial infection, more frequent NCU-discharge review of
lower risk neonates could help decongest NCUs by ensuring that infants only stay as long as
necessary. Once again, availability of affordable and reliable TSB testing within the NCU could
facilitate this, by proving prompt assessments of TSB rebound.
Beyond the comparisons in this paper, it should be noted that other options are available
for treatment of jaundice in LRSs, including promising results with UV-filtered sunlight to
treat infant with TSB <257 μmol/L [26, 27]. For infants with higher TSB requiring rapid TSB
reduction, it is common for clinicians to use multiple machine simultaneously, where
available.
This study has some limitations. First, because the Firefly cannot be used with an overhead
heater, or within an incubator, the results can only be generalised to environments that allow
for treatment without personalised heating, and to infants that can thermoregulate within that
environment. While exclusion criteria were set lower, the study only enrolled infants born at
35 weeks’ gestation, weighing1,900g, so results can only be generalised to this population.
To minimise workload, we did not collect data on infants who declined to participate or who
were excluded, so we are unable to comment on the impact of refusals or exclusions. Second,
an observational study design with un-blinded quasi-randomised allocation process was cho-
sen for practical reasons. Average TSB and age at commencement of treatment resulted imbal-
anced across the treatment arms, but they were included as confounders in all multivariable
analyses. Finally, the study did not constrain clinical decisions about the distance of the bulb
units from the infant, or their use of high and low intensity modes (options available in the sin-
gle-sided machines). Although these aspects may have affected some observed differences
between single- and double-sided phototherapy, our findings nevertheless demonstrated the
advantages of double-sided high-intensity phototherapy in actual use in a real world LRS.
Conclusions
We found no difference in the effectiveness of the two single-sided LED machines in terms of
speed of reduction of TSB, duration of treatment or LOS in the NCU. Compared to single-
sided machines, the double-sided machine showed a 45–54% increase in the rate of TSB reduc-
tion and a 14-hour reduction in both the duration of treatment and LOS in the NCU. Long-
lasting LED phototherapy units eliminate the need for frequent replacement of bulbs, making
it an affordable technology for LRSs and creating the opportunity for high quality photother-
apy to be consistently provided. To maximise the benefit in terms of appropriateness of care
and reduction in average patient load in the NCU and treatment of more infants on a single
device, introduction of more effective phototherapy should be accompanied by review of stan-
dard practices of patient review and discharge to optimise the timing of treatment cessation
and patient discharge.
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